Refine
Has Fulltext
- yes (37)
Is part of the Bibliography
- yes (37)
Year of publication
Document Type
- Journal article (37)
Language
- English (37)
Keywords
- osteoporosis (4)
- hypophosphatasia (3)
- mechanotransduction (3)
- mineralization (3)
- sarcopenia (3)
- HPP (2)
- LMHFV (2)
- Mesenchymal stem cells (2)
- Multiple myeloma (2)
- TNAP (2)
- back pain (2)
- bone-mineral density (2)
- differentiation (2)
- exercise (2)
- fracture (2)
- fracture healing (2)
- in-vitro (2)
- inflammation (2)
- model (2)
- nervous system (2)
- oestrogen receptor signalling (2)
- stromal cells (2)
- teriparatide (2)
- 2',7'-dichlorofluorescin (1)
- 3D printing (1)
- ALPL (1)
- Angiopoietin-like 4 (1)
- Bioreaktor (1)
- Bisphosphonates (1)
- Bone Mineral Density (1)
- Bone disease (1)
- Breast cancer cells (1)
- CCN1 (1)
- Caspase 3/7 activity (1)
- Cell viability, (1)
- EQ-5D (1)
- ER signaling (1)
- Endothelial growth-factor (1)
- Gene expression profiling (1)
- Hypophosphatasia (1)
- Mechanical strain (1)
- Medizin (1)
- Novobiocin (1)
- Osteogenic precursor cells (1)
- Probenecid (1)
- RT-PCR (1)
- Splicing (1)
- WNT pathway (1)
- WNT signaling pathway (1)
- WNT5A (1)
- Wnt (1)
- Wnt signalling (1)
- Wnt-signalling (1)
- Wnt/β-catenin signaling (1)
- additive manufacturing (1)
- age (1)
- age-related osteoporosis (1)
- aging (1)
- alendronate (1)
- alkaline phosphatase (1)
- alkaline-phosphatase (1)
- alpha (1)
- angiogenic cytokines (1)
- aseptic loosening (1)
- asfotase alfa (1)
- autologous chondrocyte implantation (1)
- autosomal-dominant osteopetrosis (1)
- biceps tendon (1)
- biodegradable polymers (1)
- biomarkers Myelomas (1)
- bioreactor (1)
- bisphosphonates (1)
- bone (1)
- bone QCT (1)
- bone biology (1)
- bone formation (1)
- bone imaging (1)
- bone marrow (1)
- bone marrow lesion/edema (1)
- bone marrow stromal cells (1)
- bone mineral density (1)
- bone remodeling (1)
- bone tumour (1)
- cancer microenvironment (1)
- cardiovascular (1)
- cells (1)
- cellular signalling networks (1)
- click chemistry (1)
- colony-stimulating factor (1)
- community-dwelling (1)
- computer modelling (1)
- core depression (1)
- craniosynostosis (1)
- database (1)
- early stage (1)
- epidermal growth factor (1)
- expression (1)
- fluorescence microscopy (1)
- fluorescent dyes (1)
- gene (1)
- gene constructs (1)
- gene-expression (1)
- glycocalyx (1)
- growth factor (1)
- hMSC-TERT (1)
- health-related quality of life (1)
- high-bone-mass (1)
- homeostasis (1)
- human atherosclerotic lesions (1)
- hypovitaminosis D (1)
- impact (1)
- in situ guided tissue regeneration (1)
- in situ hybridization (1)
- in vitro (1)
- level mechanical vibrations (1)
- lines (1)
- malignancy (1)
- marrow stromal cells (1)
- mechanosensing (1)
- mechanosensitive reporter (1)
- men (1)
- mesenchymal cells (1)
- mesenchymal stem cell (1)
- mesenchymal stem cells (1)
- mesenchymal stem-cells (1)
- mesenchymal stromal cells (1)
- mesenchymal tissues (1)
- metaanalysis (1)
- metabolic glycoengineering (1)
- metabolic risk (1)
- metabolic syndrome (1)
- metabolism (1)
- microstructures (1)
- mineraliztion (1)
- modified monosaccharides (1)
- monoclonial gammopathy (1)
- morphogenetic protein (1)
- multiple myeloma Lesions (1)
- muscle (1)
- mutant mice (1)
- mutations (1)
- myeloma (1)
- myeloma cells (1)
- myokines (1)
- nanostructures (1)
- neurotransmission (1)
- nonspecific alkaline-phosphae (1)
- obesity (1)
- older people (1)
- osteoblastic cells (1)
- osteochondral allografts (1)
- osteoclasts (1)
- osteogenesis imperfecta (1)
- osteogenic differentiation (1)
- osteokines adaptation (1)
- osteomalacia (1)
- osteopenia (1)
- ovariectomized rats (1)
- ovariectomy (1)
- overview (1)
- oxidative stress (1)
- parathyroid-hormone (1)
- peripheral-blood (1)
- persistence (1)
- perspectives (1)
- precedes multiple-myeloma (1)
- prevalent fractures (1)
- progenitor cells (1)
- proliferation (1)
- promotes (1)
- quality of life (1)
- rare bone disease (1)
- receptor beta (1)
- receptor related protein (1)
- regenerative capacity (1)
- regenerative medicine (1)
- replacement therapy (1)
- replicative senescence (1)
- resistance exercise (1)
- responsiveness (1)
- rickets (1)
- scaffolds (1)
- segmental collapse (1)
- senescence (1)
- senescence‐associated secretory phenotype (1)
- serum amyloid A (1)
- sheep model (1)
- shoulder (1)
- signaling (1)
- skeletal overexpression (1)
- stem cells (1)
- teeth (1)
- tendon-derived stem cell (1)
- tissue (1)
- tissue engineering (1)
- toll-like receptor (1)
- transcription factors (1)
- tumour malignancy (1)
- undetermined significance (1)
- vertebral fractures (1)
- vertebrate (1)
- vitamin D (1)
- vitamin D deficiency (1)
- vitamin-D-receptor (1)
- whole body vibration (1)
- whole-body electromyostimulation (1)
- whole-body vibration (1)
- zebrafish (1)
- zoledronic acid (1)
Institute
- Lehrstuhl für Orthopädie (37) (remove)
EU-Project number / Contract (GA) number
- 241719 (1)
- 242175 (1)
- 617989 (1)
- EU-1650-0006 (1)
In situ guided tissue regeneration, also addressed as in situ tissue engineering or endogenous regeneration, has a great potential for population-wide “minimal invasive” applications. During the last two decades, tissue engineering has been developed with remarkable in vitro and preclinical success but still the number of applications in clinical routine is extremely small. Moreover, the vision of population-wide applications of ex vivo tissue engineered constructs based on cells, growth and differentiation factors and scaffolds, must probably be deemed unrealistic for economic and regulation-related issues. Hence, the progress made in this respect will be mostly applicable to a fraction of post-traumatic or post-surgery situations such as big tissue defects due to tumor manifestation. Minimally invasive procedures would probably qualify for a broader application and ideally would only require off the shelf standardized products without cells. Such products should mimic the microenvironment of regenerating tissues and make use of the endogenous tissue regeneration capacities. Functionally, the chemotaxis of regenerative cells, their amplification as a transient amplifying pool and their concerted differentiation and remodeling should be addressed. This is especially important because the main target populations for such applications are the elderly and diseased. The quality of regenerative cells is impaired in such organisms and high levels of inhibitors also interfere with regeneration and healing. In metabolic bone diseases like osteoporosis, it is already known that antagonists for inhibitors such as activin and sclerostin enhance bone formation. Implementing such strategies into applications for in situ guided tissue regeneration should greatly enhance the efficacy of tailored procedures in the future.